Cantor Fitzgerald Assumes Paratek Pharmaceuticals (PRTK) at Buy
Tweet
Share
E-mailGet Alerts PRTK Hot Sheet
Price: $2.23 --0%
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Cantor Fitzgerald assumed coverage on Paratek Pharmaceuticals (NASDAQ: PRTK) with a Buy rating and a price target of $27.00.
For an analyst ratings summary and ratings history on Paratek Pharmaceuticals click here. For more ratings news on Paratek Pharmaceuticals click here.
Shares of Paratek Pharmaceuticals closed at $15.98 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Milestone Pharmaceuticals (MIST) at Overweight
- Barclays Starts Bitdeer Technologies Group (BTDR) at Overweight
- Piper Sandler Starts Madison Square Garden Entertainment (MSGE) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
